Skip to main content
Evidence Based Longevity (EBL)Check what I take
← All devices
B

Hyperbaric & compression · graded by use, two uses

Pneumatic Lymphatic Compression

Clinical lymphedema.

Compare this record with another, side by side →

In plain words

Pneumatic compression uses a sleeve that inflates and squeezes the limb in cycles. A review of 7 recent trials in adults with long-term leg swelling from lymphedema found a benefit on limb volume. Most of these adults were women around age 55. After hard exercise, it did not speed recovery of jumping or muscle strength. A possible drop in soreness came from one trial and rests on people's own ratings.

The B belongs to one of the two uses graded on this record. The other one carries its own letter.

Grades by use · each use graded on its own evidence
BClinical lymphedemameasured function
As studied, and the trials
As studied
DoseDaily treatment in 5 of 7 trials, twice-daily sessions in 4; session length and pressure not stated (O'Donnell 2026, PMID PubMed ID: the permanent number the US National Library of Medicine gives a published paper. Each one links to that paper's record on PubMed. 41997536).
FormIntermittent pneumatic compression; an advanced pneumatic compression device in 5 of 7 trials, combined with complex decongestive therapy in 3; comparators were complex decongestive therapy, simple IPC or a different device mode (O'Donnell 2026 systematic review A review that searches for every study on a question using a method set in advance, then assesses them together., PMID 41997536).
PopulationAdults 18 or older with chronic lower extremity lymphedema present 6 months or more, in the maintenance phase: 7 randomized trials, about 54 patients each, mean age 55 years, 67 percent female, mostly secondary lymphedema, chronic venous insufficiency the most common cause (O'Donnell 2026, PMID 41997536).
Duration4 weeks in 3 trials, 5 weeks in 1 and 8 months in 1 (O'Donnell 2026, PMID 41997536).
DExercise recovery, objective function (jump, MVC)measured function
As studied, and the trials

Read the grade that matches your goal. How EBL grades by use →

B Grade B

A letter describes the human evidence, not the product, the manufacturer, or the intervention's worth.

See the full evidence record →

Graded on Limb volume reduction (clinical lymphedema).

Why this gradeThe reasoning, and what the grade does not cover.
Why this grade

Grade B on limb volume in clinical lymphedema, resting on a systematic review of contemporary randomized trials of intermittent pneumatic compression (O'Donnell et al., 2026; PMID 41997536). For exercise recovery the use is graded D: compression did not improve objective recovery of jump or maximal contraction (PMIDs 39416507 and 40555415).

WHAT THIS GRADE DOES NOT COVERsports recovery, where the possible reduction in soreness is self-reported and unreplicated; wellness or detox claims; and lymphedema prevention in people without the condition.

A grade describes the human evidence for a named use. It is not advice, and it is not a judgment on any individual prescription. How the letters are decided →

Each use, with its trials
Graded by use

This record carries a separate letter for each thing it has been measured on. The headline grade is the best of them, and it does not transfer to the others.

B Clinical lymphedema

D Exercise recovery, objective function (jump, MVC)

The evidence, in fullOne paper, linked to its PubMed record.
The evidence

O'Donnell et al. (Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2026; PMID 41997536): systematic review of contemporary randomized trials of intermittent pneumatic compression in clinical lymphedema. Grade B rests on this review and on the limb-volume endpoint The outcome a trial measures to decide whether the treatment worked, such as heart attacks, blood pressure or a symptom score. alone. The two Maia trials (PMIDs 39416507 and 40555415) are sports-recovery studies in athletes; they carry the separate Grade D on exercise recovery and are not evidence for the lymphedema letter.

What to track

Limb circumference at standardized anatomical points at baseline and every 4 weeks. Subjective limb heaviness and fatigue using a validated scale monthly. Session frequency, pressure settings, and garment coverage must match the studied protocol for the specific indication.

Evidence notes: meta-analysis A study that pools the numbers from several trials into one combined estimate., randomized trial

Endpoint graded: Limb volume reduction (clinical lymphedema) (functional)

Last reviewed: July 2026

Educational use only · Not medical advice · EBL grades published human evidence and does not recommend treatment. Stopping a prescription is a decision for your physician.

Primary evidenceOne paper, linked to its PubMed record.
Primary evidence

O'Donnell et al. (Journal of Vascular Surgery: Venous and Lymphatic Disorders, 2026; PMID 41997536): systematic review of contemporary randomized trials of intermittent pneumatic compression in clinical lymphedema. Grade B rests on this review and on the limb-volume endpoint alone. The two Maia trials (PMIDs 39416507 and 40555415) are sports-recovery studies in athletes; they carry the separate Grade D on exercise recovery and are not evidence for the lymphedema letter.

Products listed under this therapy

Products carry no letter. The letter belongs to the therapy as the trials studied it, and no trial tested these products unless the entry says so. Listed alphabetically; payment does not affect order.

AIROS 8 Sequential Compression Device
AIROS Medical · FDA cleared The FDA found a device substantially equivalent to one already on the market. Clearance is not approval and does not require trials showing benefit. (K172779)

Eight-chamber sequential pneumatic compression device for the arms, legs and trunk, used in the treatment of lymphedema and venous disorders. Available with a prescription, per the manufacturer.

EBL earns no commission on this product.
Flexitouch Plus
Tactile Medical · FDA cleared (K203178)

Pneumatic compression system with garments for the legs, trunk and chest, for home treatment of lymphedema under medical supervision. Prescription only.

EBL earns no commission on this product.
Flowpresso
Flowpresso · Status unverified

3-in-1: compression + heat + deep pressure therapy. Full-body suit design. Combines thermal and mechanical stimulation. Designed for clinic and professional wellness use.

EBL earns no commission on this product.
Independence
EBL earns nothing on this record.

This page carries a letter. EBL takes no commission, referral fee or payment of any kind on anything it grades. No letter has been bought and none is for sale. Products listed under this modality may be commercial partners, and their purchase links may earn EBL a commission. Those products carry no letter of their own, every relationship is disclosed beside the link, and where a product does not deliver what the trials tested, this page says so regardless of who pays.

How this is enforced

That is not a promise, it is a build condition. Two checks run on every deploy: one refuses to publish if a commission is claimed on anything graded, the other refuses if a page names a commercial relationship that is not declared in the register. If either fails, this page does not go live. You can read how the checks work, and what they do not cover, on the evidence integrity page.

Evidence Trace
See the full evidence record
Every trial · every result · every withdrawn citation
→
Evidence Based Longevity, Inc. is owner-operated and edited by Arnold Sandlow, D.C., a California-licensed chiropractor. Evidence Based Longevity publishes in English only · Machine translations are not produced or reviewed by EBL for accuracy

© Evidence Based Longevity, Inc.. All rights reserved

Medical disclaimer

These statements have not been evaluated by the Food and Drug Administration. Any grade on this page describes the strength of published human trial evidence in the populations studied. It is not a recommendation for any individual and is not medical advice. Starting, stopping or changing any supplement or medication is a decision for your physician.

Grades move when new trials publish. A free monthly email lists every grade EBL moved, with the reason and the trial behind it: the sign-up is on the Evidence Log →